Mendelian Randomization Analysis
"Mendelian Randomization Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of the GENETIC VARIATION of known functions or phenotypes to correlate the causal effects of those functions or phenotypes with a disease outcome.
Below are MeSH descriptors whose meaning is more general than "Mendelian Randomization Analysis".
Below are MeSH descriptors whose meaning is more specific than "Mendelian Randomization Analysis".
This graph shows the total number of publications written about "Mendelian Randomization Analysis" by people in Harvard Catalyst Profiles by year, and whether "Mendelian Randomization Analysis" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2010 | 4 | 1 | 5 |
2011 | 3 | 3 | 6 |
2012 | 6 | 3 | 9 |
2013 | 8 | 4 | 12 |
2014 | 4 | 6 | 10 |
2015 | 5 | 18 | 23 |
2016 | 11 | 18 | 29 |
2017 | 12 | 22 | 34 |
2018 | 13 | 25 | 38 |
2019 | 13 | 42 | 55 |
2020 | 16 | 58 | 74 |
2021 | 20 | 39 | 59 |
2022 | 13 | 37 | 50 |
2023 | 1 | 35 | 36 |
Below are the most recent publications written about "Mendelian Randomization Analysis" by people in Profiles.
-
Relationships between body fat distribution and metabolic syndrome traits and outcomes: A mendelian randomization study. PLoS One. 2023; 18(10):e0293017.
-
Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1421-1435.
-
Genome-wide association studies and cross-population meta-analyses investigating short and long sleep duration. Nat Commun. 2023 09 28; 14(1):6059.
-
Identification and analysis of individuals who deviate from their genetically-predicted phenotype. PLoS Genet. 2023 09; 19(9):e1010934.
-
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 2023 09 01; 32(9):1265-1269.
-
Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses. Cell Rep Med. 2023 09 19; 4(9):101174.
-
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study. J Cancer Res Clin Oncol. 2023 Nov; 149(16):14889-14900.
-
An atlas of associations between 14 micronutrients and 22 cancer outcomes: Mendelian randomization analyses. BMC Med. 2023 08 21; 21(1):316.
-
Health Effects of Vitamin D Supplementation: Lessons Learned From Randomized Controlled Trials and Mendelian Randomization Studies. J Bone Miner Res. 2023 10; 38(10):1391-1403.
-
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization. Arthritis Rheumatol. 2023 10; 75(10):1781-1792.